-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Supplementation with omega-3 polyunsaturated fatty acids (omega-3 PUFA) and low-dose aspirin (ASA) has been proposed as a host regulatory regimen for the control of chronic inflammatory diseases
Diabetes Immunity
A total of 75 patients (n = 25/group) were enrolled in the study, and they were randomly assigned to the placebo and periodontal debridement (CG) group.
The results showed that 10 patients (40%) in the TG1 group and 9 patients (36%) in the TG2 group reached the clinical end point of the treatment (less than or equal to 4 sites with a depth of exploration ≥5 mm), while only 4 patients in the CG group (16%)
In summary, the adjuvant use of omega-3 and ASA after periodontal debridement has clinical and immunological benefits for the treatment of periodontitis in type 2 diabetic patients
Original source:
Nidia C Castro Dos Santos, et al.
Omega-3 PUFA and aspirin as adjuncts to periodontal debridement in patients with periodontitis and type 2 diabetes mellitus: Randomized clinical trial
in this message